Case of fixed-dose combination antihypertensive medications, amlodipine and losartan, intoxication

Background: Fixed-dose combination (FDC) medications are increasingly utilized in clinical practice due to their convenience and potential benefits in improving adherence. However, reports on FDC intoxication remain uncommon, and management strategies for such cases are not well established. Case: A 19-year-old female presented to the emergency department (ED) six hours after intentionally ingesting 400 mg of amlodipine and 4000 mg of losartan, components of the combination drug Amosartan-Q, which also contains rosuvastatin. Despite intensive treatment, including inotropic agents, calcium gluconate, glucagon, hyperinsulinemic-hypoglycemic therapy, and continuous renal replacement therapy, her hemodynamic status continued to deteriorate. Approximately 54 hours after arrival, she suffered pulseless electrical activity (PEA) arrest and subsequently died. Conclusions: The management of FDC drug overdose remains poorly defined, and conventional therapies are often insufficient. This case highlights a significant gap in clinical understanding and underscores the need for further research and standardized treatment protocols for FDC intoxication.

Emergency department; Fixed-dose combination medications; Poisoning; Suicide

[1] Kim HL, Lee EM, Ahn SY, Kim KI, Kim HC, Kim JH, et al. The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension. Clinical Hypertension. 2023; 29: 11.

[2] Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends in Cardiovascular Medicine. 2020; 30: 160–164.

[3] Gupta YK, Ramachandran SS. Fixed dose drug combinations: issues and challenges in India. Indian Journal of Pharmacology. 2016; 48: 347–349.

[4] Lee HS, Han J, Kim JH, Kim S. Epidemiologic characteristics of intentional poisoning: emergency department based injury in-depth surveillance during 2011–2015. Journal of the Korean Society of Clinical Toxicology. 2017; 15: 131–139.

[5] Prescribing Information. Review and assessment service. 2020. Accessible at: http://data.medigate.net/search (Accessed: 24 October 2024).

[6] Kim KW, Yoon SK, Jung WS. Clinical toxicology. 1st edn. Koon Ja: Seoul. 2006.

[7] van Zwieten P. Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties. Clinical Cardiology. 1994; 17: III3–III6.

[8] Heynen G. Amlodipine: pharmacokinetic and pharmacodynamic profile of a calcium antagonist with prolonged effect. Revue Suisse de Medecine Praxis. 1992; 81: 199–203. (In German)

[9] Kumar K, Biyyam M, Bajantri B, Nayudu S. Critical management of severe hypotension caused by amlodipine toxicity managed with hyperinsulinemia/euglycemia therapy supplemented with calcium gluconate, intravenous glucagon and other vasopressor support: review of literature. Cardiology Research. 2018; 9: 46–49.

[10] Schult RF, Nacca N, Grannell TL, Jorgensen RM, Acquisto NM. Evaluation of high-dose insulin/euglycemia therapy for suspected β-blocker or calcium channel blocker overdose following guideline implementation. American Journal of Health-System Pharmacy. 2022; 79: 547–555.

[11] Koliastasis L, Lampadakis I, Milkas A, Strempelas P, Sourides V, Kakava K, et al. Refractory shock from amlodipine overdose overcomed with hyperinsulinemia. Cardiovascular toxicology. 2022; 22: 63–66.

[12] Chou YJ, Lee CH. Success in early treatment with lipid emulsion for antihypertension drug overdose patient. The American Journal of Emergency Medicine. 2021; 50: 814.e3–814.e5.

[13] Mégarbane B. High‐dose insulin should be used before vasopressors/inotropes in calcium‐channel blocker toxicity. British Journal of Clinical Pharmacology. 2023; 89: 1269–1274.

[14] Lamore R, Wani A, Jarrah A, Lacovara L, Bass GD. The use of methylene blue for refractory distributive shock secondary to calcium channel blocker overdose. Journal of Medical Case Reports and Case Series. 2024; 5: 1–3.

[15] Jouffroy R, Pegat-Toquet A, Bourdiault A, Philippe P, Carli P, Vivien B. Refractory vasodilatory shock induced by Irbesartan’s acute intoxication. Clinical Medical Reviews and Case Reports. 2018; 5: 218.

[16] Huang J, Buckley NA, Isoardi KZ, Chiew AL, Isbister GK, Cairns R, et al. Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning. Clinical Toxicology. 2021; 59: 464–471.

[17] Duburcq T, Goutay J, Preau S, Mugnier A, Rousse N, Moussa MD, et al. Venoarterial extracorporeal membrane oxygenation in severe drug intoxication: a retrospective comparison of survivors and nonsurvivors. ASAIO Journal. 2022; 68: 907–913.

[18] Pozzi M, Buzzi R, Hayek A, Portran P, Schweizer R, Fellahi JL, et al. Veno‐arterial extracorporeal membrane oxygenation for drug intoxications: A single center, 14‐year experience. Journal of Cardiac Surgery. 2022; 37: 1512–1519.

[19] Bhandary SP, Joseph N, Hofmann JP, Saranteas T, Papadimos TJ. Extracorporeal life support for refractory ventricular tachycardia. Annals of Translational Medicine. 2017; 5: 73.

[20] Upchurch C, Blumenberg A, Brodie D, MacLaren G, Zakhary B, Hendrickson RG. Extracorporeal membrane oxygenation use in poisoning: a narrative review with clinical recommendations. Clinical Toxicology. 2021; 59: 877–887.

[21] Ng M, Wong ZY, Ponampalam R. Extracorporeal cardio-pulmonary resuscitation in poisoning: a scoping review article. Resuscitation Plus. 2023; 13: 100367.

[22] Yusuke M, Hidetoshi Y, Yusuke T, Koji I, Masahito T, Susumu Y, et al. Intoxication with massive doses of amlodipine and candesartan requiring venoarterial extracorporeal membrane oxygenation. Acute Medicine & Surgery. 2023; 10: e878.

[23] Weinberg R, Bouchard N, Abrams D, Bacchetta M, Dzierba AL, Burkart KM, et al. Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose. Perfusion. 2014; 29: 53–56.

[24] Sutar A, Venkategowda PM, Murthy A, Chikkaswamy SB. Severe amlodipine toxicity: a case rescued with extracorporeal membrane oxygenation. Indian Journal of Critical Care Medicine. 2020; 24: 365–366.

[25] Ideno S, Nakada T, Oiwa T, Kobari M, Yaguchi A. Case of olmesartan and amlodipine intoxication. The Japanese Journal of Toxicology. 2011; 24: 236–240. (In Japanese)